DE3069587D1 - 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof - Google Patents

1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof

Info

Publication number
DE3069587D1
DE3069587D1 DE8080301900T DE3069587T DE3069587D1 DE 3069587 D1 DE3069587 D1 DE 3069587D1 DE 8080301900 T DE8080301900 T DE 8080301900T DE 3069587 T DE3069587 T DE 3069587T DE 3069587 D1 DE3069587 D1 DE 3069587D1
Authority
DE
Germany
Prior art keywords
sulpho
production
pharmaceutical compositions
oxoazetidine derivatives
oxoazetidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080301900T
Other languages
English (en)
Inventor
Taisuke Matsuo
Tohru Sugawara
Hirotomo Masuya
Yasuhiko Kawano
Michihico Ochiai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7281379A external-priority patent/JPS55164672A/ja
Priority claimed from JP3636680A external-priority patent/JPS56133260A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE3069587D1 publication Critical patent/DE3069587D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8080301900T 1979-06-08 1980-06-06 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof Expired DE3069587D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7281379A JPS55164672A (en) 1979-06-08 1979-06-08 Azetidine derivative and its preparation
JP3636680A JPS56133260A (en) 1980-03-22 1980-03-22 Azetidine derivative and its preparation

Publications (1)

Publication Number Publication Date
DE3069587D1 true DE3069587D1 (en) 1984-12-13

Family

ID=26375410

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080301900T Expired DE3069587D1 (en) 1979-06-08 1980-06-06 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof

Country Status (3)

Country Link
EP (1) EP0021678B1 (de)
CA (1) CA1338538C (de)
DE (1) DE3069587D1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196202A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Beta-lactam antibiotics (of azetidine-sulphonic acid type)
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
EP0048953B1 (de) * 1980-09-29 1988-03-09 E.R. Squibb & Sons, Inc. Beta-Lactam-Antibiotika
EP0050965A1 (de) * 1980-10-23 1982-05-05 Takeda Chemical Industries, Ltd. Beta-Lactamase inhibierende Zusammensetzung
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
WO1982001871A1 (en) * 1980-12-03 1982-06-10 Ochiai Michihiko Process for preparing a 1-sulfo-2-oxoazetidine derivative
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
MX7096E (es) * 1980-12-05 1987-06-19 Takeda Chemical Industries Ltd Metodo para preparacion de derivados de 2-oxoazetidina
US4625022A (en) * 1981-02-02 1986-11-25 E. R. Squibb & Sons, Inc. Process for preparing (s)-3-amino-2-oxo-1-azetidinesulfonic acid salts
AU557649B2 (en) * 1981-03-30 1987-01-08 E.R. Squibb & Sons, Inc. 4-substituted mercapto-2-oxo-1-azetidinesulfonic acid salts
US4478749A (en) * 1981-03-30 1984-10-23 E. R. Squibb & Sons, Inc. 2-Oxo-1-(substituted phosphorous)azetidines
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
US4483797A (en) * 1981-04-27 1984-11-20 E. R. Squibb & Sons, Inc. (S)-3-Isocyanato-2-oxo-1-azetidinesulfonic acids
US4734496A (en) * 1981-05-29 1988-03-29 E. R. Squibb & Sons, Inc. 4-amino derivatives of 2-oxo-1-azetidinesulfonic acid salts
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
FR2509726B1 (de) * 1981-07-16 1984-04-27 Squibb & Sons Inc
US4499016A (en) * 1981-08-06 1985-02-12 E. R. Squibb & Sons, Inc. 2-Oxo-1-[(acylamino)sulfonyl]azetidines
EP0187355A1 (de) * 1981-09-23 1986-07-16 E.R. Squibb & Sons, Inc. Verfahren zur Herstellung von beta-Lactam-Antibiotika
FR2515182B1 (fr) * 1981-10-23 1986-05-09 Roussel Uclaf Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation
EP0086563A1 (de) * 1982-01-22 1983-08-24 Beecham Group Plc Antibakteriel wirkende Mittel, ihre Herstellung und Verwendung
DE3368266D1 (en) * 1982-05-24 1987-01-22 Squibb & Sons Inc 2-oxo-1-(thiophosphonic or thiophosphinic)-azetidines
HU189290B (en) * 1982-05-31 1986-06-30 Banyu Pharmaceutical Co Ltd,Jp Process for preparing new 2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutically acceptable salts thereof, further pharmaceutical compositions containing such derivatives as active substances
EP0096296B1 (de) * 1982-06-03 1987-07-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 1-Sulfo-2-oxoazetidinderivate
EP0096297B1 (de) * 1982-06-03 1988-06-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von 1-Sulfo-2-oxoazetidinderivaten
US4652651A (en) * 1983-05-31 1987-03-24 Hoffmann-La Roche Inc. Process for the manufacture of 1-sulpho-2-oxoazetidine carboxylic acid intermediates via catalytic ester cleavage
DE3340006A1 (de) * 1983-11-04 1985-05-23 Hans Rudolf Prof. Dipl.-Chem. Dr. 8000 München Pfaendler Verfahren zur herstellung von azetidin-2-onen
CA2266639A1 (en) * 1996-09-23 1998-03-26 Rajeshwar Singh 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2278335A1 (fr) * 1974-07-04 1976-02-13 Fujisawa Pharmaceutical Co Derives d'azetidinones et leurs procedes de preparation
GB1570278A (en) * 1975-10-06 1980-06-25 Fujisawa Pharmaceutical Co O-substituted-2-azetidinone derivatives and the preparation thereof
IL52685A (en) * 1976-08-09 1982-11-30 Shionogi & Co 3-amino-2-oxo-azetidinyl acetic acid derivatives,their preparation and a process for the preparation of 1-dethia-1-oxa-cephalosporins

Also Published As

Publication number Publication date
EP0021678B1 (de) 1984-11-07
CA1338538C (en) 1996-08-20
EP0021678A1 (de) 1981-01-07

Similar Documents

Publication Publication Date Title
DE3069587D1 (en) 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof
DE3068020D1 (en) Aminoalkylbenzene derivatives, process for their preparation and pharmaceutical compositions
PH16519A (en) 1,2,3,4-tetrahydro-2-amino-5-oxy-naphthalene derivatives and their pharmaceutical compositions
DE2966635D1 (en) New pleuromutilin derivatives, their production and pharmaceutical compositions containing them
IL56017A (en) 5-cyano-prostacyclin derivatives,their manufacture and pharmaceutical compositions containing them
IL57229A (en) Hydroxypropyl-imidazole derivatives,their production and pharmaceutical compositions containing them
DE3062884D1 (en) Spiro-hydantoin derivatives, process for their preparation and pharmaceutical compositions thereof
IL60037A (en) Pyrazinobenzodiazepines,their production and pharmaceutical compositions containing them
IL59391A0 (en) Cephalosporin derivatives,their production and pharmaceutical compositions containing them
IL53332A (en) 3-fluoro-6-piperazino-morphanthridine derivatives,their production and pharmaceutical compositions containing them
DE3069716D1 (en) Dibenzazepine derivatives, their production and pharmaceutical compositions containing them
ZA794580B (en) N-phenylindoline derivatives,their production and pharmaceutical compositions containing them
IL54105A (en) 2-acylamino-4-amino-5-benzylpyrimidine derivatives,their production and pharmaceutical compositions containing them
IL61335A0 (en) 1-oxadethiacephalosporin derivatives, their production and pharmaceutical compositions containing them
IL61040A0 (en) Pyridazopyridazine derivatives,their manufacture and pharmaceutical compositions containing them
IL60733A0 (en) Pyrrolidine derivatives,their manufacture and pharmaceutical compositions containing them
IL61773A0 (en) Pyrrolobenzotriazepines,their production and pharmaceutical compositions containing them
DE3061160D1 (en) 15-methanesulfonamidoprostaglandin derivatives, pharmaceutical compositions thereof and process therefor
IL56696A0 (en) Nitroso-urea derivatives,their production and pharmaceutical compositions containing them
IL54342A (en) 2,3 -dihydroergolen-8 -ylmethylurea derivatives, their production and pharmaceutical compositions containing them
IL55651A0 (en) Thienobenzazepine derivatives,their production and pharmaceutical compositions containing them
IL56529A0 (en) Azathianaphthalene derivatives, their manufacture and pharmaceutical compositions containing them
IL54614A0 (en) New pyrandoquinoline derivatives, their production and pharmaceutical compositions containing them
IL57885A (en) Oxadiazolotriazine derivatives,their manufacture and pharmaceutical compositions containing them
IL55007A (en) Benzisoindoline derivatives,their production and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee